TEMAZEPAM - AN OVERVIEW

glycerol phenylbutyrate will decrease the extent or impact of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check. Glycerol phenylbutyrate is usually a weak inducer of CYP3A4. Monitor for reduced efficacy of CYP3A4 substrates that have a slim therapeutic index.Stay clear of concomitant utilization of tucatinib wi